Insulin resistance in patients with polycystic ovary syndrome
- PMID: 15513294
- DOI: 10.1080/07853890410035296
Insulin resistance in patients with polycystic ovary syndrome
Abstract
With a prevalence of 5%-10% the polycystic ovary syndrome (PCOS) is an exceptionally common disorder of premenopausal women. According to prospective studies, women with PCOS present abnormal glucose tolerance and diabetes mellitus in 31%-35% and 7.5%-10%, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension, type 2 diabetes and dyslipidaemia. The rate of spontaneous abortions as well as the risk to develop gestational or type 2 diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem but a complex endocrine disease with important health implications. The role of the glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.
Similar articles
-
Type 2 diabetes and the polycystic ovary syndrome.Minerva Ginecol. 2004 Feb;56(1):41-51. Minerva Ginecol. 2004. PMID: 14973409 Review.
-
Insulin resistance and polycystic ovary syndrome.Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):511-8. doi: 10.1016/j.numecd.2008.05.004. Epub 2008 Jul 25. Nutr Metab Cardiovasc Dis. 2008. PMID: 18657405 Review.
-
An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.Metabolism. 2008 Jul;57(7):954-60. doi: 10.1016/j.metabol.2008.02.011. Metabolism. 2008. PMID: 18555837 Clinical Trial.
-
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.Neuro Endocrinol Lett. 2007 Dec;28(6):807-10. Neuro Endocrinol Lett. 2007. PMID: 18063948
-
Polycystic ovary syndrome and type 2 diabetes mellitus.Minerva Ginecol. 2004 Feb;56(1):53-62. Minerva Ginecol. 2004. PMID: 14973410 Review.
Cited by
-
A Novel Genes Signature Associated with the Progression of Polycystic Ovary Syndrome.Pathol Oncol Res. 2020 Jan;26(1):575-582. doi: 10.1007/s12253-019-00676-3. Epub 2019 Jul 5. Pathol Oncol Res. 2020. PMID: 31278444
-
Irpex lacteus polysaccharide exhibits therapeutic potential for ovarian fibrosis in PCOS rats via the TGF-β1/smad pathway.Heliyon. 2023 Jul 27;9(8):e18741. doi: 10.1016/j.heliyon.2023.e18741. eCollection 2023 Aug. Heliyon. 2023. PMID: 37554783 Free PMC article.
-
Misrepresentation of semaglutide in social media.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 19. doi: 10.1007/s00210-025-04403-5. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40682686
-
The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome.J Ovarian Res. 2015 Nov 6;8:71. doi: 10.1186/s13048-015-0197-4. J Ovarian Res. 2015. PMID: 26545735 Free PMC article.
-
Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature.J Healthc Eng. 2022 Mar 21;2022:9240569. doi: 10.1155/2022/9240569. eCollection 2022. J Healthc Eng. 2022. PMID: 35356614 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical